Research Article

Neuroprotective Effects of Cistanches Herba Therapy on Patients with Moderate Alzheimer’s Disease

Figure 1

Participant outcomes at pre-and posttreatment. Data were expressed as mean ± SD. (a) MMSE: minimental state examination; (b) ADAS-cog: Alzheimer’s disease assessment scale-cognitive subscale; outcomes of drug treatment groups were better than control group at 48 weeks ().
(a)
(b)